Educational information, reviewed by Ryan Arvizo, FNP-C. Current as of September 2026. Not legal or medical advice. Current as of September 2026.
New Mexico was one of the first states to let nurse practitioners practice independently, and its rules for telehealth are straightforward. Three layers decide what is lawful: federal FDA rules on the medication, New Mexico law on the prescriber and the visit, and the pharmacy that fills the prescription.
Layer 1: federal rules on the medication itself
FDA-approved medications can be prescribed. Compounded medications are not FDA-approved and may only be compounded from ingredients the FDA permits; the FDA removed twelve peptides from its restricted list in April 2026 and an advisory committee recommended several for compounding in July 2026, with rulemaking still to finish. Compounded GLP-1s narrowed to patient-specific compounding after the shortage ended. Our national guide on whether peptide therapy is legal in 2026 has the detail.
Layer 2: New Mexico law on the prescriber and the visit
- Independent nurse practitioner practice. Under NMSA § 61-3-23.2, certified nurse practitioners practice independently, make decisions about a patient’s health care needs, and may prescribe dangerous drugs and Schedule II–V controlled substances in accordance with Board of Nursing rules. No physician collaboration agreement is required.
- Telehealth. New Mexico permits licensed providers to deliver care by telehealth, held to the same standard of care as in-person visits. BioPeakRx evaluations are synchronous audio-video visits with a provider licensed for New Mexico.
- Testosterone (Schedule III) may currently be prescribed after an audio-video telehealth evaluation without a prior in-person visit under the federal telemedicine flexibilities that run through December 31, 2026.
- New Mexico Medicaid covers other weight-loss drugs but not GLP-1s for obesity under fee-for-service, so most New Mexico GLP-1 care is cash-pay.
Layer 3: the pharmacy
New Mexico licenses out-of-state pharmacies that ship into the state. BioPeakRx prescriptions are filled by a state-licensed, FDA-registered 503A sterile compounding pharmacy that holds a New Mexico nonresident sterile pharmacy license, on your individual prescription only. Compounded medications are not FDA-approved.
What this means for you
A New Mexico resident can be evaluated by a nurse practitioner by telehealth and, when clinically appropriate, prescribed FDA-approved or lawfully compounded medication filled by a pharmacy licensed for New Mexico. We do not bill insurance or Medicaid. The Provider Evaluation is free — the $110 fee was removed — and your medication is one all-in monthly price, with no membership fee, quoted to you before you pay. BioPeakRx serves Albuquerque, Rio Rancho, Santa Fe, Las Cruces, and the rest of New Mexico.
Sources
- New Mexico Statutes, § 61-3-23.2, Certified nurse practitioner; qualifications; practice
- Center for Connected Health Policy, New Mexico telehealth laws and policies
- FDA, Human Drug Compounding
- FDA, July 23–24, 2026 Meeting of the Pharmacy Compounding Advisory Committee
- DEA, DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care
- KFF, Medicaid Coverage of and Spending on GLP-1s
This information is educational and is not medical or legal advice. It is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved. Treatments require evaluation by a licensed provider.